Teva sues FDA over bid to block approval of generic Copaxone
Teva sues FDA over bid to block approval of generic Copaxone
Teva Pharmaceutical Industries Ltd. sued U.S. regulators seeking to block approval of a generic version of its multiple-sclerosis drug Copaxone, a product that accounts for more than half the company’s revenue and is set to go off patent on May 24............ Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/
Re: Teva sues FDA over bid to block approval of generic Copa
Teva loses suit against FDA over generic form of Copaxone
Teva Pharmaceutical Industries Ltd. lost a bid to block approval of a generic form of Copaxone, a multiple sclerosis drug that may account for half the company’s profit, 10 days before the patent on the medication expires........... Read More - http://www.ms-uk.org/copaxone
Teva Pharmaceutical Industries Ltd. lost a bid to block approval of a generic form of Copaxone, a multiple sclerosis drug that may account for half the company’s profit, 10 days before the patent on the medication expires........... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/